deficiency common genetic defect associated development severe rapidly progressive lung disease study undertaken determine respiratory physicians manage patients aat deficiency differently patients chronic obstructive pulmonary disease copd deficiency addition obtained physicians views tested aat deficiency questionnaire administered NUMBER respiratory physicians based uk NUMBER teaching hospitals main outcome measures pulmonary function tests radiological assessment frequency repeat testing screening protocol deficiency subjects homozygous piz aat deficiency likely NUMBER baseline pulmonary function testing including dynamic flow rates static lung volumes gas transfer NUMBER comprehensive assessment high resolution computed tomography hrct thorax repeated radiological assessment annual chest radiography NUMBER routinely NUMBER family members tested deficiency testing remains limited aat deficiency mainly restricted young patients copd copd assessment management influenced presence aat deficiency reflect poorer prognosis patients rapid decline assessment monitoring simplified forced expired manoeuvres limited hrct thorax tests gas transfer prove sensitive progression emphysema testing aat deficiency uk remains restricted influence detection rate aat deficiency wider policy testing advocated detect patients influence understanding natural history condition alpha NUMBER antitrypsin alpha NUMBER antitrypsin alpha NUMBER antitrypsin follow alpha NUMBER antitrypsin followed alpha NUMBER antitrypsin